582 related articles for article (PubMed ID: 33933056)
1. Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis.
Han AL
BMC Endocr Disord; 2021 May; 21(1):91. PubMed ID: 33933056
[TBL] [Abstract][Full Text] [Related]
2. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.
Chang Y; Ryu S; Sung KC; Cho YK; Sung E; Kim HN; Jung HS; Yun KE; Ahn J; Shin H; Wild SH; Byrne CD
Gut; 2019 Sep; 68(9):1667-1675. PubMed ID: 30472683
[TBL] [Abstract][Full Text] [Related]
3. Alcoholic and Nonalcoholic Fatty Liver Disease and Incident Hospitalization for Liver and Cardiovascular Diseases.
Chang Y; Cho J; Cho YK; Cho A; Hong YS; Zhao D; Ahn J; Sohn CI; Shin H; Guallar E; Ryu S
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):205-215.e7. PubMed ID: 31085337
[TBL] [Abstract][Full Text] [Related]
4. Alcoholic fatty liver disease elevates estimated coronary heart disease risk to levels comparable with those of nonalcoholic fatty liver disease in the Korean population: a cross-sectional study.
Kim HJ; Kim JH; Choe WH; Kwon SY; Lee CH
Clin Mol Hepatol; 2014 Jun; 20(2):154-61. PubMed ID: 25032181
[TBL] [Abstract][Full Text] [Related]
5. Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).
Johnston MP; Patel J; Byrne CD
Curr Pharm Des; 2020; 26(10):1079-1092. PubMed ID: 32003662
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey.
Kotronen A; Yki-Järvinen H; Männistö S; Saarikoski L; Korpi-Hyövälti E; Oksa H; Saltevo J; Saaristo T; Sundvall J; Tuomilehto J; Peltonen M
BMC Public Health; 2010 May; 10():237. PubMed ID: 20459722
[TBL] [Abstract][Full Text] [Related]
7. Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.
Veronese N; Notarnicola M; Cisternino AM; Reddavide R; Inguaggiato R; Guerra V; Rotolo O; Zinzi I; Leandro G; Correale M; Tutino V; Misciagna G; Osella AR; Bonfiglio C; Giannelli G; Caruso MG;
Nutrients; 2018 Jan; 10(1):. PubMed ID: 29342916
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease.
Haflidadottir S; Jonasson JG; Norland H; Einarsdottir SO; Kleiner DE; Lund SH; Björnsson ES
BMC Gastroenterol; 2014 Sep; 14():166. PubMed ID: 25260964
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease.
Yu CW; Chen CH; Cheng YC; Hsieh WC; Hsu TJ; Tsai FJ; Hsu CY
Eur J Med Res; 2023 Dec; 28(1):550. PubMed ID: 38042817
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
[TBL] [Abstract][Full Text] [Related]
11. Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease.
Sookoian S; Pirola CJ
PLoS One; 2013; 8(3):e58895. PubMed ID: 23516571
[TBL] [Abstract][Full Text] [Related]
12. Carotid intima-media thickness is increased not only in non-alcoholic fatty liver disease patients but also in alcoholic fatty liver patients.
Kim JH; Kim SY; Jung ES; Jung SW; Koo JS; Kim JH; Yeon JE; Kwon SY; Lee SW; Byun KS; Lee CH
Digestion; 2011; 84(2):149-55. PubMed ID: 21525770
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.
Muzurović E; Mikhailidis DP; Mantzoros C
Metabolism; 2021 Jun; 119():154770. PubMed ID: 33864798
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes.
Käräjämäki AJ; Bloigu R; Kauma H; Kesäniemi YA; Koivurova OP; Perkiömäki J; Huikuri H; Ukkola O
Metabolism; 2017 Jan; 66():55-63. PubMed ID: 27423871
[TBL] [Abstract][Full Text] [Related]
16. Association between toothbrushing and non-alcoholic fatty liver disease.
Kim JY; Park YM; Lee GN; Song HC; Ahn YB; Han K; Ko SH
PLoS One; 2021; 16(5):e0243686. PubMed ID: 34043630
[TBL] [Abstract][Full Text] [Related]
17. Impact of metabolic risk factors on hepatic and cardiac outcomes in patients with alcohol- and non-alcohol-related fatty liver disease.
Lim J; Sang H; Kim HI
JHEP Rep; 2023 Jun; 5(6):100721. PubMed ID: 37138675
[TBL] [Abstract][Full Text] [Related]
18. The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification.
Cho YK; Kang YM; Yoo JH; Lee J; Lee SE; Yang DH; Kang JW; Park JY; Jung CH; Kim HK; Lee WJ
Sci Rep; 2018 Aug; 8(1):12004. PubMed ID: 30104707
[TBL] [Abstract][Full Text] [Related]
19. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
[TBL] [Abstract][Full Text] [Related]
20. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.
Chinnadurai R; Chrysochou C; Kalra PA
Nephron; 2019; 141(1):24-30. PubMed ID: 30384370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
